A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapy.
Nichol A, Chung P, Lockwood G, Rosewall T, Divanbiegi L, Sweet J, Toi A, Bayley A, Bristow R, Crook J, Gospodarowicz M, McLean M, Milosevic M, Warde P, Catton C.
Nichol A, et al.
Radiother Oncol. 2005 Jul;76(1):11-7. doi: 10.1016/j.radonc.2005.06.002.
Radiother Oncol. 2005.
PMID: 15990187
Clinical Trial.